Literature DB >> 18832475

Quantitation of human cytochrome P450 2D6 protein with immunoblot and mass spectrometry analysis.

Ai-Ming Yu1, Jun Qu, Melanie A Felmlee, Jin Cao, Xi-Ling Jiang.   

Abstract

Accurate quantification of cytochrome P450 (P450) protein contents is essential for reliable assessment of drug safety, including the prediction of in vivo clearance from in vitro metabolism data, which may be hampered by the use of uncharacterized standards and existence of unknown allelic isozymes. Therefore, this study aimed to delineate the variability in absolute quantification of polymorphic CYP2D6 drug-metabolizing enzyme and compare immunoblot and nano liquid chromatography coupled to mass spectrometry (nano-LC/MS) methods in identification and relative quantification of CYP2D6.1 and CYP2D6.2 allelic isozymes. Holoprotein content of in-house purified CYP2D6 isozymes was determined according to carbon monoxide difference spectrum, and total protein was quantified with bicinchoninic acid protein assay. Holoprotein/total CYP2D6 protein ratio was markedly higher for purified CYP2D6.1 (71.0%) than that calculated for CYP2D6.1 Supersomes (35.5%), resulting in distinct linear calibration range (0.05-0.50 versus 0.025-0.25 pmol) that was determined by densitometric analysis of immunoblot bands. Likewise, purified CYP2D6.2 and CYP2D6.10 and the CYP2D6.10 Supersomes all showed different holoprotein/total CYP2D6 protein ratios and distinct immunoblot linear calibration ranges. In contrast to immunoblot, nano-LC/MS readily distinguished CYP2D6.2 (R296C and S486T) from CYP2D6.1 by isoform-specific proteolytic peptides that contain the altered amino acid residues. In addition, relative quantitation of the two allelic isozymes was successfully achieved with label-free protein quantification, consistent with the nominated ratio. Because immunoblot and nano-LC/MS analyses measure total P450 protein (holoprotein and apoprotein) in a sample, complete understanding of holoprotein and apoprotein contents in P450 standards is desired toward reliable quantification. Our data also suggest that nano-LC/MS not only facilitates P450 quantitation but also provides genotypic information.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832475      PMCID: PMC2683657          DOI: 10.1124/dmd.108.024166

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  37 in total

1.  Production of inhibitory polyclonal antibodies against cytochrome P450s.

Authors:  Poh-Sing Ng; Susumu Imaoka; Toyoko Hiroi; Mayuko Osada; Toshio Niwa; Tetsuya Kamataki; Yoshihiko Funae
Journal:  Drug Metab Pharmacokinet       Date:  2003       Impact factor: 3.614

2.  Disparity in holoprotein/apoprotein ratios of different standards used for immunoquantification of hepatic cytochrome P450 enzymes.

Authors:  H F Perrett; Z E Barter; B C Jones; H Yamazaki; G T Tucker; A Rostami-Hodjegan
Journal:  Drug Metab Dispos       Date:  2007-06-28       Impact factor: 3.922

3.  Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization.

Authors:  E M Gillam; Z Guo; M V Martin; C M Jenkins; F P Guengerich
Journal:  Arch Biochem Biophys       Date:  1995-06-01       Impact factor: 4.013

4.  Sex is a major determinant of CYP3A4 expression in human liver.

Authors:  Renzo Wolbold; Kathrin Klein; Oliver Burk; Andreas K Nüssler; Peter Neuhaus; Michel Eichelbaum; Matthias Schwab; Ulrich M Zanger
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

5.  Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation.

Authors:  A C Kempf; U M Zanger; U A Meyer
Journal:  Arch Biochem Biophys       Date:  1995-08-20       Impact factor: 4.013

6.  Precolumn derivatization of cysteine residues for quantitative analysis of five major cytochrome P450 isoenzymes by liquid chromatography/tandem mass spectrometry.

Authors:  Xiaotao Duan; Xiaoyan Chen; Yiming Yang; Dafang Zhong
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

7.  Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation.

Authors:  J Gut; R Gasser; P Dayer; T Kronbach; T Catin; U A Meyer
Journal:  FEBS Lett       Date:  1984-08-06       Impact factor: 4.124

Review 8.  Progress towards prediction of human pharmacokinetic parameters from in vitro technologies.

Authors:  J Brian Houston; Aleksandra Galetin
Journal:  Drug Metab Rev       Date:  2003-11       Impact factor: 4.518

9.  The human intestinal cytochrome P450 "pie".

Authors:  Mary F Paine; Heather L Hart; Shana S Ludington; Robert L Haining; Allan E Rettie; Darryl C Zeldin
Journal:  Drug Metab Dispos       Date:  2006-02-07       Impact factor: 3.922

10.  Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice.

Authors:  Melanie A Felmlee; Hoi-Kei Lon; Frank J Gonzalez; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2007-11-29       Impact factor: 3.922

View more
  7 in total

1.  Pivotal role of P450-P450 interactions in CYP3A4 allostery: the case of α-naphthoflavone.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; Elena V Sineva; Irina Kufareva; James R Halpert
Journal:  Biochem J       Date:  2013-07-15       Impact factor: 3.857

Review 2.  Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics.

Authors:  Deepak Kumar Bhatt; Bhagwat Prasad
Journal:  Clin Pharmacol Ther       Date:  2017-09-25       Impact factor: 6.875

3.  Pinoline may be used as a probe for CYP2D6 activity.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2008-12-18       Impact factor: 3.922

4.  MicroRNAs regulate CYP3A4 expression via direct and indirect targeting.

Authors:  Yu-Zhuo Pan; Wenqing Gao; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2009-07-06       Impact factor: 3.922

5.  Cell cycle-related cyclin b1 quantification.

Authors:  Phyllis S Frisa; James W Jacobberger
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

6.  Effects of alcohol-induced increase in CYP2E1 content in human liver microsomes on the activity and cooperativity of CYP3A4.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Marc A Maldonado; Armina Abbasi; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Arch Biochem Biophys       Date:  2020-11-13       Impact factor: 4.013

7.  Spaceflight Effects on Cytochrome P450 Content in Mouse Liver.

Authors:  Natalia Moskaleva; Alexander Moysa; Svetlana Novikova; Olga Tikhonova; Victor Zgoda; Alexander Archakov
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.